Tag: Pharma

STAT+: New tumor cases show common gene therapy tool can come with risk

Health & well-being news
For two decades, researchers debated whether adeno-associated viruses, the small viruses used to deliver new genes into thousands of...

STAT+: Amgen’s Repatha linked to fewer heart attacks

Health & well-being news
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in...

STAT+: Pharmalittle: We’re reading about a Novartis gene therapy, faster U.K. drug reviews, and more

Health & well-being news
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is,...

STAT+: Pharma critic Bernie Sanders is set to hold major sway over FDA funding bill

Health & well-being news
WASHINGTON – Democrats’ landslide victory in the midterm elections may have significant implications for the upcoming negotiations over a...

STAT+: Ultragenyx cuts staff after another study fails 

Health & well-being news
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in...

STAT+: Servier’s $1.55 billion muscular dystrophy drug fails first major test

Health & well-being news
The French pharma Servier said Tuesday that an experimental drug it purchased in June for $1.55 billion in cash,...

STAT+: Biopharma industry at odds over impact of Treasury’s new China rule

Health & well-being news
WASHINGTON — Ever since the Treasury Department proposed to limit U.S. investment in the Chinese biotech industry last week,...

STAT+: HHS moves to allow compounding of some unapproved peptides

Health & well-being news
WASHINGTON — The Department of Health and Human Services released a policy that will temporarily allow compounding pharmacies to...